United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

HIV/AIDS data from the HIV Surveillance Annual Report Data reported to the HIV Epidemiology Program by March 31, 2022. All data shown are for people ages 18 and older. Borough-wide and citywide totals may include cases assigned to a borough with an unknown UHF or assigned to NYC with an unknown borough, respectively. Therefore, UHF totals may not sum to borough totals and borough totals may not sum to citywide totals.""

These data were reported to the NYC DOHMH by March 31, 2021

This dataset includes data on new diagnoses of HIV and AIDS in NYC for the calendar years 2016 through 2020. Reported cases and case rates (per 100,000 population) are stratified by United Hospital Fund (UHF) neighborhood, sex, and race/ethnicity.

Abstract

The 2005 Guyana HIV/AIDS Indicator Survey (GAIS) is the first household-based, comprehensive survey on HIV/AIDS to be carried out in Guyana. The 2005 GAIS was implemented by the Guyana Responsible Parenthood Association (GRPA) for the Ministry of Health (MoH). ORC Macro of Calverton, Maryland provided technical assistance to the project through its contract with the U.S. Agency for International Development (USAID) under the MEASURE DHS program. Funding to cover technical assistance by ORC Macro and for local costs was provided in their entirety by USAID/Washington and USAID/Guyana.

The 2005 GAIS is a nationally representative sample survey of women and men age 15-49 initiated by MoH with the purpose of obtaining national baseline data for indicators on knowledge/awareness, attitudes, and behavior regarding HIV/AIDS. The survey data can be effectively used to calculate valuable indicators of the President’s Emergency Plan for AIDS Relief (PEPFAR), the Joint United Nations Program on HIV/AIDS (UNAIDS), the United Nations General Assembly Special Session (UNGASS), the United Nations Children Fund (UNICEF) Orphan and Vulnerable Children unit (OVC), and the World Health Organization (WHO), among others. The overall goal of the survey was to provide program managers and policymakers involved in HIV/AIDS programs with information needed to monitor and evaluate existing programs; and to effectively plan and implement future interventions, including resource mobilization and allocation, for combating the HIV/AIDS epidemic in Guyana.

Other objectives of the 2005 GAIS include the support of dissemination and utilization of the results in planning, managing and improving family planning and health services in the country; and enhancing the survey capabilities of the institutions involved in order to facilitate the implementation of surveys of this type in the future.

The 2005 GAIS sampled over 3,000 households and completed interviews with 2,425 eligible women and 1,875 eligible men. In addition to the data on HIV/AIDS indicators, data on the characteristics of households and its members, malaria, infant and child mortality, tuberculosis, fertility, and family planning were also collected.

Geographic coverage

National

Analysis unit

• Individuals;
• Households.

Kind of data

Sample survey data [ssd]

Sampling procedure

The primary objective of the 2005 GAIS is to provide estimates with acceptable precision for important population characteristics such as HIV/AIDS related knowledge, attitudes, and behavior. The population to be covered by the 2005 GAIS was defined as the universe of all women and men age 15-49 in Guyana.

The major domains to be distinguished in the tabulation of important characteristics for the eligible population are: • Guyana as a whole • The urban area and the rural area each as a separate major domain • Georgetown and the remainder urban areas.

Administratively, Guyana is divided into 10 major regions. For census purposes, each region is further subdivided in enumeration districts (EDs). Each ED is classified as either urban or rural. There is a list of EDs that contains the number of households and population for each ED from the 2002 census. The list of EDs is grouped by administrative units as townships. The available demarcated cartographic material for each ED from the last census makes an adequate sample frame for the 2005 GAIS.

The sampling design had two stages with enumeration districts (EDs) as the primary sampling units (PSUs) and households as the secondary sampling units (SSUs). The standard design for the GAIS called for the selection of 120 EDs. Twenty-five households were selected by systematic random sampling from a full list of households from each of the selected enumeration districts for a total of 3,000 households. All women and men 15-49 years of age in the sample households were eligible to be interviewed with the individual questionnaire.

The database for the recently completed 2002 Census was used as a sampling frame to select the sampling units. In the census frame, EDs are grouped by urban-rural location within the ten administrative regions and they are also ordered in each administrative unit in serpentine fashion. Therefore, this stratification and ordering will be also reflected in the 2005 GAIS sample.

Based on response rates from other surveys in Guyana, around 3,000 interviews of women and somewhat fewer of men expected to be completed in the 3,000 households selected.

Several allocation schemes were considered for the sample of clusters for each urban-rural domain. One option was to allocate clusters to urban and rural areas proportionally to the population in the area. According to the census, the urban population represents only 29 percent of the population of the country. In this case, around 35 clusters out of the 120 would have been allocated to the urban area. Options to obtain the best allocation by region were also examined. It should be emphasized that optimality is not guaranteed at the regional level but the power for analysis is increased in the urban area of Georgetown by departing from proportionality. Upon further analysis of the different options, the selection of an equal number of clusters in each major domain (60 urban and 60 rural) was recommended for the 2005 GAIS. As a result of the nonproportionalallocation of the number of EDs for the urban-rural and regional domains, the household sample for the 2005 GAIS is not a self-weighted sample.

The 2005 GAIS sample of households was selected using a stratified two-stage cluster design consisting of 120 clusters. The first stage-units (primary sampling units or PSUs) are the enumeration areas used for the 2002 Population and Housing Census. The number of EDs (clusters) in each domain area was calculated dividing its total allocated number of households by the sample take (25 households for selection per ED). In each major domain, clusters are selected systematically with probability proportional to size.

The sampling procedures are more fully described in "Guyana HIV/AIDS Indicator Survey 2005 - Final Report" pp.135-138.

Mode of data collection

Face-to-face [f2f]

Research instrument

Two types of questionnaires were used in the survey, namely: the Household Questionnaire and the Individual Questionnaire. The contents of these questionnaires were based on model questionnaires developed by the MEASURE DHS program. In consultation with USAID/Guyana, MoH, GRPA, and other government agencies and local organizations, the model questionnaires were modified to reflect issues relevant to HIV/AIDS in Guyana. The questionnaires were finalized around mid-May.

The Household Questionnaire was used to list all the usual members and visitors in the selected households. For each person listed, information was collected on sex, age, education, and relationship to the head of the household. An important purpose of the Household Questionnaire was to identify women and men who were eligible for the individual interview.

The Household Questionnaire also collected non-income proxy indicators about the household's dwelling unit, such as the source of water; type of toilet facilities; materials used for the floor, roof and walls of the house; and ownership of various durable goods and land. As part of the Malaria Module, questions were included on ownership and use of mosquito bednets.

The Individual Questionnaire was used to collect information from women and men age 15-49 years and covered the following topics: • Background characteristics (age, education, media exposure, employment, etc.) • Reproductive history (number of births and—for women—a birth history, birth registration, current pregnancy, and current family planning use) • Marriage and sexual activity • Husband’s background • Knowledge about HIV/AIDS and exposure to specific HIV-related mass media programs • Attitudes toward people living with HIV/AIDS • Knowledge and experience with HIV testing • Knowledge and symptoms of other sexually transmitted infections (STIs) • The malaria module and questions on tuberculosis

Cleaning operations

The processing of the GAIS questionnaires began in mid-July 2005, shortly after the beginning of fieldwork and during the first visit of the ORC Macro data processing specialist. Questionnaires for completed clusters (enumeration districts) were periodically submitted to GRPA offices in Georgetown, where they were edited by data processing personnel who had been trained specifically for this task. The concurrent processing of the data—standard for surveys participating in the DHS program—allowed GRPA to produce field-check tables to monitor response rates and other variables, and advise field teams of any problems that were detected during data entry. All data were entered twice, allowing 100 percent verification. Data processing, including data entry, data editing, and tabulations, was done using CSPro, a program developed by ORC Macro, the U.S. Bureau of Census, and SERPRO for processing surveys and censuses. The data entry and editing of the questionnaires was completed during a second visit by the ORC Macro specialist in mid-September. At this time, a clean data set was produced and basic tables with the basic HIV/AIDS indicators were run. The tables included in the current report were completed by the end of November 2005.

Response rate

• From a total of 3,055 households in the sample, 2,800 were occupied. Among these households, interviews were completed in 2,608, for a response rate of 93 percent. • A total of 2,776 eligible women were identified and

This dataset helps to investigate the Spatial Accessibility to HIV Testing, Treatment, and Prevention Services in Illinois and Chicago, USA. The main components are: population data, healthcare data, GTFS feeds, and road network data. The core components are: 1) GTFS which contains GTFS (General Transit Feed Specification) data which is provided by Chicago Transit Authority (CTA) from Google's GTFS feeds. Documentation defines the format and structure of the files that comprise a GTFS dataset: https://developers.google.com/transit/gtfs/reference?csw=1. 2) HealthCare contains shapefiles describing HIV healthcare providers in Chicago and Illinois respectively. The services come from Locator.HIV.gov. 3) PopData contains population data for Chicago and Illinois respectively. Data come from The American Community Survey and AIDSVu. AIDSVu (https://map.aidsvu.org/map) provides data on PLWH in Chicago at the census tract level for the year 2017 and in the State of Illinois at the county level for the year 2016. The American Community Survey (ACS) provided the number of people aged 15 to 64 at the census tract level for the year 2017 and at the county level for the year 2016. The ACS provides annually updated information on demographic and socio economic characteristics of people and housing in the U.S. 4) RoadNetwork contains the road networks for Chicago and Illinois respectively from OpenStreetMap using the Python osmnx package. The abstract for our paper is: Accomplishing the goals outlined in “Ending the HIV (Human Immunodeficiency Virus) Epidemic: A Plan for America Initiative” will require properly estimating and increasing access to HIV testing, treatment, and prevention services. In this research, a computational spatial method for estimating access was applied to measure distance to services from all points of a city or state while considering the size of the population in need for services as well as both driving and public transportation. Specifically, this study employed the enhanced two-step floating catchment area (E2SFCA) method to measure spatial accessibility to HIV testing, treatment (i.e., Ryan White HIV/AIDS program), and prevention (i.e., Pre-Exposure Prophylaxis [PrEP]) services. The method considered the spatial location of MSM (Men Who have Sex with Men), PLWH (People Living with HIV), and the general adult population 15-64 depending on what HIV services the U.S. Centers for Disease Control (CDC) recommends for each group. The study delineated service- and population-specific accessibility maps, demonstrating the method’s utility by analyzing data corresponding to the city of Chicago and the state of Illinois. Findings indicated health disparities in the south and the northwest of Chicago and particular areas in Illinois, as well as unique health disparities for public transportation compared to driving. The methodology details and computer code are shared for use in research and public policy.

This dataset is about countries in Central America. It has 8 rows. It features 3 columns: incidence of HIV, and urban population.

The Find Ryan White HIV/AIDS Medical Care Providers tool is a locator that helps people living with HIV/AIDS access medical care and related services. Users can search for Ryan White-funded medical care providers near a specific complete address, city and state, state and county, or ZIP code.

Search results are sorted by distance away and include the Ryan White HIV/AIDS facility name, address, approximate distance from the search point, telephone number, website address, and a link for driving directions.

HRSA's Ryan White program funds an array of grants at the state and local levels in areas where most needed. These grants provide medical and support services to more than a half million people who otherwise would be unable to afford care.

This collection consists of geospatial data layers and summary data at the country and country sub-division levels that are part of USAID's Demographic Health Survey Spatial Data Repository. This collection includes geographically-linked health and demographic data from the DHS Program and the U.S. Census Bureau for mapping in a geographic information system (GIS). The data includes indicators related to: fertility, family planning, maternal and child health, gender, HIV/AIDS, literacy, malaria, nutrition, and sanitation. Each set of files is associated with a specific health survey for a given year for over 90 different countries that were part of the following surveys:Demographic Health Survey (DHS)Malaria Indicator Survey (MIS)Service Provisions Assessment (SPA)Other qualitative surveys (OTH)Individual files are named with identifiers that indicate: country, survey year, survey, and in some cases the name of a variable or indicator. A list of the two-letter country codes is included in a CSV file.Datasets are subdivided into the following folders:Survey boundaries: polygon shapefiles of administrative subdivision boundaries for countries used in specific surveys. Indicator data: polygon shapefiles and geodatabases of countries and subdivisions with 25 of the most common health indicators collected in the DHS. Estimates generated from survey data.Modeled surfaces: geospatial raster files that represent gridded population and health indicators generated from survey data, for several countries.Geospatial covariates: CSV files that link survey cluster locations to ancillary data (known as covariates) that contain data on topics including population, climate, and environmental factors.Population estimates: spreadsheets and polygon shapefiles for countries and subdivisions with 5-year age/sex group population estimates and projections for 2000-2020 from the US Census Bureau, for designated countries in the PEPFAR program.Workshop materials: a tutorial with sample data for learning how to map health data using DHS SDR datasets with QGIS. Documentation that is specific to each dataset is included in the subfolders, and a methodological summary for all of the datasets is included in the root folder as an HTML file. File-level metadata is available for most files. Countries for which data included in the repository include: Afghanistan, Albania, Angola, Armenia, Azerbaijan, Bangladesh, Benin, Bolivia, Botswana, Brazil, Burkina Faso, Burundi, Cape Verde, Cambodia, Cameroon, Central African Republic, Chad, Colombia, Comoros, Congo, Congo (Democratic Republic of the), Cote d'Ivoire, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Eswatini (Swaziland), Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guinea, Guyana, Haiti, Honduras, India, Indonesia, Jordan, Kazakhstan, Kenya, Kyrgyzstan, Lesotho, Liberia, Madagascar, Malawi, Maldives, Mali, Mauritania, Mexico, Moldova, Morocco, Mozambique, Myanmar, Namibia, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Paraguay, Peru, Philippines, Russia, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, South Africa, Sri Lanka, Sudan, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Uganda, Ukraine, Uzbekistan, Viet Nam, Yemen, Zambia, Zimbabwe

Global Health Outcomes Data

Impact on Mortality Rates and Malnutrition in Countries Around the World

By Humanitarian Data Exchange [source]

About this dataset

This dataset provides comprehensive insights into critical health conditions around the world, such as mortality rate, malnutrition levels, and frequency of preventable diseases. It documents the prevalence of life-threatening diseases like malaria and tuberculosis, and are tracked alongside key health indicators like adult mortality rates, HIV prevalence, physicians per 10,000 people ratio and public health expenditures. Such metrics provide us with an accurate picture of how developed healthcare systems are in certain countries which ultimately leads to improvements in public policy formation and awareness amongst decision-makers. With this data it is possible to observe disparities between different regions of the world which can help inform global strategies for providing equitable care globally. This dataset is a valuable source for researchers interested in understanding global health trends over time or seeking to evaluate regional differences within countries

More Datasets

For more datasets, click here.

Featured Notebooks

• 🚨 Your notebook can be here! 🚨!

How to use the dataset

This dataset provides comprehensive global health outcome data for countries around the world. It includes vital information such as infant mortality rates, child malnutrition rates, adult mortality rates, deaths due to malaria and tuberculosis, HIV prevalence rates, life expectancy at age 60 and public health expenditure. This dataset can be used to gain valuable insight into the challenges faced by different countries in providing a good quality of life for their citizens.

To use this dataset, first identify what questions you need answered and what outcomes you are looking to measure. You may want to look at specific disease-based indicators (e.g. malaria or tuberculosis), health-related indicators (e.g., nutrition), or overall population markers (e.g., life expectancy).

Then decide which data points from the provided fields will help answer your questions and provide the results needed - e.g,. infant mortality rate or HIV prevalence rate - extracting these values from relevant columns like “Infants lacking immunization (% of one-year-olds) Measles 2013” or “HIV prevalence, adult (% ages 15Ð49) 2013” respectively

Next extract other columnwise relevant information - e.g., country name — that could also aid your analysis using tools like Excel or Python's Pandas library; sorting through them based on any metric desired — e..g,, physicians per 10k people — while being mindful that some data points are missing in some cases (denoted by NA).

Finally perform basic analyses with either your own scripting language, like R/Python libraries' numerical functions with accompanying visuals/graphs etc if elucidating trends is desired; drawing meaningful conclusions about overall state of global health outcomes accordingly before making informed decisions thereafter if needed too!

Research Ideas

• Create a world health map to visualize the differences in health outcomes across different countries and regions.
• Develop an AI-based decision support tool that identifies optimal public health policies or interventions based on these metrics for different countries.
• Design a dashboard or web app that displays and updates this data in real-time, to allow users to compare the current state of global health indicators and benchmark them against historical figures

Acknowledgements

If you use this dataset in your research, please credit the original authors. Data Source

License

License: CC0 1.0 Universal (CC0 1.0) - Public Domain Dedication No Copyright - You can copy, modify, distribute and perform the work, even for commercial purposes, all without asking permission. See Other Information.

Columns

File: health-outcomes-csv-1.csv | Column name | Description | |:-------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------------------------------------| | Country | The name of the country. (String) ...

This indicator provides information about the rate of persons living with HIV (persons per 100,000 population).Human immunodeficiency virus (HIV) infection remains a significant public health concern, with more than 59,000 Los Angeles County residents estimated to be currently living with HIV. Certain communities, such as low-income communities, communities of color, and sexual and gender minority communities, bear a disproportionate burden of this epidemic. The Ending the HIV Epidemic national initiative strives to eliminate the US HIV epidemic by 2030, focusing on four key strategies: Diagnose, Treat, Prevent, and Respond. Achieving this goal requires a collaborative effort involving cities, community organizations, faith-based institutions, healthcare professionals, and businesses. Together, they can create an environment that promotes prevention, reduces stigma, and empowers individuals to safeguard themselves and their partners from HIV. Stakeholders can advance health equity by focusing on the most affected communities and sub-populations.For more information about the Community Health Profiles Data Initiative, please see the initiative homepage.

Forecast: Incidence of HIV Among People Aged 50+ in the US 2022 - 2026 Discover more data with ReportLinker!

BackgroundIn 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-exposure prophylaxis (PrEP) is an effective strategy that reduces the risk of HIV acquisition; however, uptake among those who can benefit from it has lagged. In this study, we 1) compared the characteristics of patients who were prescribed PrEP with individuals newly diagnosed with HIV infection, 2) identified the specialties of practitioners prescribing PrEP, 3) identified metropolitan statistical areas (MSAs) within the US where there is relatively low uptake of PrEP, and 4) reported median amounts paid by patients and third-party payors for PrEP.Methods and findingsWe analyzed prescription drug claims for individuals prescribed PrEP in the Integrated Dataverse (IDV) from Symphony Health for the period of September 2015 to August 2016 to describe PrEP patients, prescribers, relative uptake, and payment methods in the US. Data were available for 75,839 individuals prescribed PrEP, and findings were extrapolated to approximately 101,000 individuals, which is less than 10% of the 1.1 million adults for whom PrEP was indicated. Compared to individuals with newly diagnosed HIV infection, PrEP patients were more likely to be non-Hispanic white (45% versus 26.2%), older (25% versus 19% at ages 35–44), male (94% versus 81%), and not reside in the South (30% versus 52% reside in the South).Using a ratio of the number of PrEP patients within an MSA to the number of newly diagnosed individuals with HIV infection, we found MSAs with relatively low uptake of PrEP were concentrated in the South. Of the approximately 24,000 providers who prescribed PrEP, two-thirds reported primary care as their specialty. Compared to the types of payment methods that people living with diagnosed HIV (PLWH) used to pay for their antiretroviral treatment in 2015 to 2016 reported in the Centers for Disease Control and Prevention (CDC) HIV Surveillance Special Report, PrEP patients were more likely to have used commercial health insurance (80% versus 35%) and less likely to have used public healthcare coverage or a publicly sponsored assistance program to pay for PrEP (12% versus 45% for Medicaid). Third-party payors covered 95% of the costs of PrEP. Overall, we estimated the median annual per patient out-of-pocket spending on PrEP was approximately US$72. Limitations of this study include missing information on prescription claims of patients not included in the database, and for those included, some patients were missing information on patient diagnosis, race/ethnicity, educational attainment, and income (34%–36%).ConclusionsOur findings indicate that in 2015–2016, many individuals in the US who could benefit from being on PrEP were not receiving this HIV prevention medication, and those prescribed PrEP had a significantly different distribution of characteristics from the broader population that is at risk for acquiring HIV. PrEP patients were more likely to pay for PrEP using commercial or private insurance, whereas PLWH were more likely to pay for their antiretroviral treatment using publicly sponsored programs. Addressing the affordability of PrEP and otherwise promoting its use among those with indications for PrEP represents an important opportunity to help end the HIV epidemic.

The 2011 Uganda AIDS Indicator Survey (AIS) is a nationally representative, population-based, HIV serological survey. The survey was designed to obtain national and sub-national estimates of the prevalence of HIV and syphilis infection as well as information about other indicators of programme coverage, such as knowledge, attitudes, and sexual behaviour related to HIV/AIDS. Data collection took place from 8 February to the first few days of September 2011. The UAIS was implemented by the Ministry of Health. ICF International provided financial and technical assistance for the survey through a contract with USAID/Uganda. Financial and technical assistance was also provided by the U.S. Centers for Disease Control and Prevention (CDC). Financial support was provided by the Government of Uganda, the U.S. Agency for International Development (USAID), the President’s Emergency Fund for AIDS Relief (PEPFAR), the World Health Organisation (WHO), the UK Department for International Development (DFID), and the Danish International Development Agency (DANIDA) through the Partnership Fund. The Uganda Bureau of Statistics also partnered in the implementation of the survey. Central testing was conducted at the Uganda Virus Research Institute, with CDC conducting CD4 counts, polymerase chain reaction (PCR) testing for children, and quality control tests. The survey provided information on knowledge, attitudes, and behaviour regarding HIV/AIDS and indicators of coverage and access to other programmes, for example, HIV testing, access to antiretroviral therapy, services for treating sexually transmitted infections, and coverage of interventions to prevent motherto-child transmission of HIV. The survey also collected information on the prevalence of HIV and syphilis and their social and demographic variations in the country. The overall goal of the survey was to provide programme managers and policymakers involved in HIV/AIDS programmes with strategic information to effectively plan, implement, and evaluate HIV/AIDS interventions. The information obtained from the survey will help programme implementers to monitor and evaluate existing programmes and design new strategies for combating the HIV/AIDS epidemic in Uganda. The survey data will in addition be used to make population projections and to calculate indicators developed by the UN General Assembly Special Session (UNGASS), USAID, PEPFAR, the UNAIDS Programme, WHO, the Uganda Health Sector Strategic and Investment Plan, and the Uganda AIDS Commission. The specific objectives of the 2011 UAIS were to provide information on: • Prevalence and distribution of HIV and syphilis • Indicators of knowledge, attitudes, and behaviour related to HIV/AIDS and other sexually transmitted infections • HIV/AIDS programme coverage indicators • Levels of CD4 T-lymphocyte counts among HIV-positive adults to quantify HIV treatment needs and to calibrate model-based estimates • HIV prevalence that can be used to calibrate and improve the sentinel surveillance system • Risk factors for HIV and syphilis infections in Uganda.

BackgroundCombination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized. We aim to estimate temporal changes in life expectancy among HIV-positive adults on ART from 2000–2007 in the U.S. and Canada.MethodsParticipants were from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), aged ≥20 years and on ART. Mortality rates were calculated using participants' person-time from January 1, 2000 or ART initiation until death, loss to follow-up, or administrative censoring December 31, 2007. Life expectancy at age 20, defined as the average number of additional years that a person of a specific age will live, provided the current age-specific mortality rates remain constant, was estimated using abridged life tables.ResultsThe crude mortality rate was 19.8/1,000 person-years, among 22,937 individuals contributing 82,022 person-years and 1,622 deaths. Life expectancy increased from 36.1 [standard error (SE) 0.5] to 51.4 [SE 0.5] years from 2000–2002 to 2006–2007. Men and women had comparable life expectancies in all periods except the last (2006–2007). Life expectancy was lower for individuals with a history of injection drug use, non-whites, and in patients with baseline CD4 counts <350 cells/mm3.ConclusionsA 20-year-old HIV-positive adult on ART in the U.S. or Canada is expected to live into their early 70 s, a life expectancy approaching that of the general population. Differences by sex, race, HIV transmission risk group, and CD4 count remain.

BackgroundDynamic HIV transmission models can provide evidence-based guidance on optimal combination implementation strategies to treat and prevent HIV/AIDS. However, these models can be extremely data intensive, and the availability of good-quality data characterizing regional microepidemics varies substantially within and across countries. We aim to provide a comprehensive and transparent description of an evidence synthesis process and reporting framework employed to populate and calibrate a dynamic, compartmental HIV transmission model for six US cities.MethodsWe executed a mixed-method evidence synthesis strategy to populate model parameters in six categories: (i) initial HIV-negative and HIV-infected populations; (ii) parameters used to calculate the probability of HIV transmission; (iii) screening, diagnosis, treatment and HIV disease progression; (iv) HIV prevention programs; (v) the costs of medical care; and (vi) health utility weights for each stage of HIV disease progression. We identified parameters that required city-specific data and stratification by gender, risk group and race/ethnicity a priori and sought out databases for primary analysis to augment our evidence synthesis. We ranked the quality of each parameter using context- and domain-specific criteria and verified sources and assumptions with our scientific advisory committee.FindingsTo inform the 1,667 parameters needed to populate our model, we synthesized evidence from 59 peer-reviewed publications and 24 public health and surveillance reports and executed primary analyses using 11 data sets. Of these 1,667 parameters, 1,517 (91%) were city-specific and 150 (9%) were common for all cities. Notably, 1,074 (64%), 201 (12%) and 312 (19%) parameters corresponded to categories (i), (ii) and (iii), respectively. Parameters ranked as best- to moderate-quality evidence comprised 39% of the common parameters and ranged from 56%-60% across cities for the city-specific parameters. We identified variation in parameter values across cities as well as within cities across risk and race/ethnic groups.ConclusionsBetter integration of modelling in decision making can be achieved by systematically reporting on the evidence synthesis process that is used to populate models, and by explicitly assessing the quality of data entered into the model. The effective communication of this process can help prioritize data collection of the most informative components of local HIV prevention and care services in order to reduce decision uncertainty and strengthen model conclusions.

Although HIV caused one of the worst epidemics since the late twentieth century, China and the U.S. has made substantial progress to control the spread of HIV/AIDS. However, the trends of HIV/AIDS incidence remain unclear in both countries. Therefore, this study aimed to highlight the long-term trends of HIV/AIDS incidence by gender in China and the U.S. population. The data were retrieved from the Global Burden of Disease (GBD) database since it would be helpful to assess the impact/role of designed policies in the control of HIV/AIDS incidence in both countries. The age-period-cohort (APC) model and join-point regression analysis were employed to estimate the age-period-cohort effect and the average annual percentage change (AAPC) on HIV incidence. Between 1994 and 2019, we observed an oscillating trend of the age-standardized incidence rate (ASIR) in China and an increasing ASIR trend in the U.S. Despite the period effect in China declined for both genders after peaked in 2004, the age effect in China grew among the young (from 15–19 to 25–29) and the old age groups (from 65–69 to 75–79). Similarly, the cohort effect increased among those born in the early (from 1924–1928 to 1934–1938) and the latest birth groups (from 1979–1983 to 2004–2009). In the case of the U.S., the age effect declined after it peaked in the 25–29 age group. People born in recent birth groups had a higher cohort effect than those born in early groups. In both countries, women were less infected by HIV than men. Therefore, besides effective strategies and awareness essential to protect the young age groups from HIV risk factors, the Chinese government should pay attention to the elderly who lacked family support and were exposed to HIV risk factors.

license: apache-2.0 tags: - africa - sustainable-development-goals - world-health-organization - development

  New HIV infections (per 1000 uninfected population)





  Dataset Description

This dataset provides country-level data for the indicator "3.3.1 New HIV infections (per 1000 uninfected population)" across African nations, sourced from the World Health Organization's (WHO) data portal on Sustainable Development Goals (SDGs). The data is presented in a wide… See the full description on the dataset page: https://huggingface.co/datasets/electricsheepafrica/hiv-infections-for-african-countries.

BackgroundConventional epidemiological surveillance of infectious diseases is focused on characterization of incident infections and estimation of the number of prevalent infections. Advances in methods for the analysis of the population-level genetic variation of viruses can potentially provide information about donors, not just recipients, of infection. Genetic sequences from many viruses are increasingly abundant, especially HIV, which is routinely sequenced for surveillance of drug resistance mutations. We conducted a phylodynamic analysis of HIV genetic sequence data and surveillance data from a US population of men who have sex with men (MSM) and estimated incidence and transmission rates by stage of infection.Methods and FindingsWe analyzed 662 HIV-1 subtype B sequences collected between October 14, 2004, and February 24, 2012, from MSM in the Detroit metropolitan area, Michigan. These sequences were cross-referenced with a database of 30,200 patients diagnosed with HIV infection in the state of Michigan, which includes clinical information that is informative about the recency of infection at the time of diagnosis. These data were analyzed using recently developed population genetic methods that have enabled the estimation of transmission rates from the population-level genetic diversity of the virus. We found that genetic data are highly informative about HIV donors in ways that standard surveillance data are not. Genetic data are especially informative about the stage of infection of donors at the point of transmission. We estimate that 44.7% (95% CI, 42.2%–46.4%) of transmissions occur during the first year of infection.ConclusionsIn this study, almost half of transmissions occurred within the first year of HIV infection in MSM. Our conclusions may be sensitive to un-modeled intra-host evolutionary dynamics, un-modeled sexual risk behavior, and uncertainty in the stage of infected hosts at the time of sampling. The intensity of transmission during early infection may have significance for public health interventions based on early treatment of newly diagnosed individuals.Please see later in the article for the Editors' Summary

This dataset contains surveillance study estimates for population size, HIV prevalence, and ART coverage among female sex workers (FSW), men who have sex with men (MSM), people who inject drugs (PWID), and transgender men and women (TGM/W) from 2010-2023. It was created to support the UNAIDS Estimates Key Population Workbook for use by HIV estimates teams in sub-Saharan Africa. Key population surveillance reports, including Ministry of Health-led biobehavioural surveys, mapping studies, and academic studies were used to populate the database.

The dataset was populated using existing key population size estimate databases including:

UNAIDS Key Population Atlas

US Centers for Disease Control and Prevention surveillance database

Global Fund against HIV/AIDS, TB, and Malaria surveillance database

Global.HIV database

Systematic review databases among MSM (Stannah et al, 2019 and Stannah et al., 2023) and PWID (Degenhardt et al., 2023)

and was additionally supplemented by a literature review of peer-reviewed and grey literature sources.

The data can be explored in this web application and the accompanying manuscript can be found here

United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data was reported at 0.020 % in 2014. This stayed constant from the previous number of 0.020 % for 2013. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data is updated yearly, averaging 0.030 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.030 % in 2012 and a record low of 0.020 % in 2014. United States US: Incidence of HIV: % of Uninfected Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Number of new HIV infections among uninfected populations ages 15-49 expressed per 100 uninfected population in the year before the period.; ; UNAIDS estimates.; Weighted Average;